相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
Julien Nicolas et al.
CHEMICAL SOCIETY REVIEWS (2013)
Modern methods for delivery of drugs across the blood-brain barrier
Yan Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
Wenxue Ma et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Transport of drugs across the blood-brain barrier by nanoparticles
Stefanie Wohlfart et al.
JOURNAL OF CONTROLLED RELEASE (2012)
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Inhibiting the Nucleation of Amyloid Structure in a Huntingtin Fragment by Targeting α-Helix-Rich Oligomeric Intermediates
Rakesh Mishra et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Slow Amyloid Nucleation via α-Helix-Rich Oligomeric Intermediates in Short Polyglutamine-Containing Huntingtin Fragments
Murali Jayaraman et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Higuchi equation: Derivation, applications, use and misuse
Juergen Siepmann et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
The Aggregation-Enhancing Huntingtin N-Terminus Is Helical in Amyloid Fibrils
V. N. Sivanandam et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
PVA hydrogel properties for biomedical application
Shan Jiang et al.
JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS (2011)
Assays for studying nucleated aggregation of polyglutamine proteins
Murali Jayaraman et al.
METHODS (2011)
Nanoprecipitation and nanoformulation of polymers: from history to powerful possibilities beyond poly(lactic acid)
Stephanie Schubert et al.
SOFT MATTER (2011)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles
Yong Zhang et al.
AAPS JOURNAL (2010)
Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease
Kirupa Sathasivam et al.
HUMAN MOLECULAR GENETICS (2010)
Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction
Tomoyuki Yamanaka et al.
HUMAN MOLECULAR GENETICS (2010)
PLGA based drug delivery systems (DDS) for the sustained release of insulin: insight into the protein/polyester interactions and the insulin release behavior
Veronica Lassalle et al.
JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY (2010)
Electrospun poly(lactic-co-glycolicacid)/halloysite nanotube composite nanofibers for drug encapsulation and sustained release
Ruiling Qi et al.
JOURNAL OF MATERIALS CHEMISTRY (2010)
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Chiara Zuccato et al.
PHYSIOLOGICAL REVIEWS (2010)
Huntington's disease: a clinical review
Raymund A. C. Roos
ORPHANET JOURNAL OF RARE DISEASES (2010)
Mutant Huntingtin N-terminal Fragments of Specific Size Mediate Aggregation and Toxicity in Neuronal Cells
Tamara Ratovitski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism
Ashwani K. Thakur et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Delivery of the aggregate inhibitor peptide QBP1 into the mouse brain using PTDs and its therapeutic effect on polyglutamine disease mice
H. Akiko Popiel et al.
NEUROSCIENCE LETTERS (2009)
Effect of formulation factors on incorporation of the hydrophilic peptide dalargin into PLGA and mPEG-PLGA nanoparticles
Y. Chen et al.
BIOPOLYMERS (2008)
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles
Christian Wischke et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Chemical degradation of peptides and proteins in PLGA: A review of reactions and mechanisms
M. L. Houchin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm to enable quantitative reverse phase high-performance liquid chromatography-mass spectrometry analysis
Bas J. H. Kuipers et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
Measurement and interpretation of electrokinetic phenomena
A. V. Delgado et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2007)
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin
Rona K. Graham et al.
CELL (2006)
Methods to assess in vitro drug release from injectable polymeric particulate systems
SS D'Souza et al.
PHARMACEUTICAL RESEARCH (2006)
Oligoproline effects on polyglutamine conformation and aggregation
A Bhattacharyya et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice
E Rodriguez-Lebron et al.
MOLECULAR THERAPY (2005)
Impurity formation studies with peptide-loaded polymeric microspheres. Part I. In vivo evaluation
SB Murty et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo
XQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles
A Bootz et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
M Tanaka et al.
NATURE MEDICINE (2004)
Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles
J Panyam et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Role of histidine interruption in mitigating the pathological effects of long polyglutamine stretches in SCA1: A molecular approach
S Sen et al.
PROTEIN SCIENCE (2003)
Mutational analysis of the structural organization of polyglutamine aggregates
AK Thakur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Amyloid-like features of polyglutamine aggregates and their assembly kinetics
SM Chen et al.
BIOCHEMISTRY (2002)
Peptide acylation by poly(α-hydroxy esters)
A Lucke et al.
PHARMACEUTICAL RESEARCH (2002)
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
C Zuccato et al.
SCIENCE (2001)
Impairment of the ubiquitin-proteasome system by protein aggregation
NF Bence et al.
SCIENCE (2001)
Solubilization and disaggregation of polyglutamine peptides
SM Chen et al.
PROTEIN SCIENCE (2001)
Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy
V Heiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
